SCNI Stock Summary and Trading Ideas (Scinai Immunotherapeutics Ltd. - American Depositary Shares | NASDAQ:SCNI)

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol SCNI.

As of January 17, 2025, SCNI stock price declined to $3.51 with 4,841 million shares trading.

SCNI has a market cap of $2.99 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that SCNI belongs to (by Net Assets): SPDW.

SCNI has underperformed the market in the last year with a price return of -34.1% while the SPY ETF gained +28.0%. SCNI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.3% and -2.5%, respectively, while the SPY returned +3.0% and +1.0%, respectively.

SCNI support price is $3.41 and resistance is $3.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCNI shares will trade within this expected range on the day.